User:Johnskad/Plasma membrane monoamine transporter/Bibliography
You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.
![]() | Bibliography
As you gather the sources for your Wikipedia contribution, think about the following:
|
Bibliography
editEdit this section to compile the bibliography for your Wikipedia assignment. Add the name and/or notes about what each source covers, then use the "Cite" button to generate the citation for that source.
Potential sources/info
- Nancy A. Muma and Zhen Mi 2015 6 (7), 961-969. Serotonylation and Transamidation of Other Monoamines, DOI: 10.1021/cn500329r
- Review article that mentions PMAT. General info: PMAT is highly expressed, especially in dendrites. Expressed in locations of high monoamine concentration and said to be an alternative mechanism to the high affinity transporters. [1]
- Nishijima H and Tomiyama M (2016) What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum? Front. Neurosci. 10:575. doi: 10.3389/fnins.2016.00575
- Mini-review article on Parkinson's; "Organic cation transporter-3 and plasma membrane monoamine transporter, low affinity, and high-capacity transporters, also potentially uptake dopamine when high-affinity transporters do not work normally." Has a figure and CC BY license.[2] "Furthermore, low affinity monoamine transporters such as OCT-3 and PMAT may be new targets to modify dopamine metabolism for PD treatment in future studies."
- Tomomi Furihata, Naohiko Anzai, Functional Expression of Organic Ion Transporters in Astrocytes and Their Potential as a Drug Target in the Treatment of Central Nervous System Diseases, Biological and Pharmaceutical Bulletin, 2017, Volume 40, Issue 8, Pages 1153-1160, Released on J-STAGE August 01, 2017, Online ISSN 1347-5215, Print ISSN 0918-6158, https://doi-org.byu.idm.oclc.org/10.1248/bpb.b17-00076, https://www-jstage-jst-go-jp.byu.idm.oclc.org/article/bpb/40/8/40_b17-00076/_article/-char/en
- Astrocytes and transporters, table with substates and Km, new inhibitor (Lopinavir) [3]
- To summarize, it is considered likely that astrocytic PMAT plays a crucial role in biogenic amine clearance in both the normal and pathological brain, thus suggesting that PMAT has significant potential to become a pharmacological target in several brain diseases.
- Lynette C. Daws, Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy, Pharmacology & Therapeutics, Volume 121, Issue 1, 2009, Pages 89-99, ISSN 0163-7258, https://doi.org/10.1016/j.pharmthera.2008.10.004.[4] (https://www.sciencedirect.com/science/article/pii/S0163725808001976)
- More new inhibitors, focus on PMAT and OCT as target for anti-depressants
- Not free - but does have snippets of all the sections
- Wagner, David J.; Hu, Tao; Wang, Joanne (2016-09). "Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics". Pharmacological Research. 111: 237–246. doi:10.1016/j.phrs.2016.06.002. ISSN1043-6618. PMC 5293005. PMID 27317943.[5]
- new substrate, in table
- Good
- Weber, Brady L.; Beaver, Jasmin N.; Gilman, T. Lee (2022-11-20). "Summarizing studies using constitutive genetic deficiency to investigate behavioural influences of uptake 2 monoamine transporters". Basic & Clinical Pharmacology & Toxicology. 133 (5): 439–458. doi:10.1111/bcpt.13810. ISSN 1742-7835.[6]
- sex differences, overview things for uptake 2
- Wang, J (2016-09-19). "The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition". Clinical Pharmacology & Therapeutics. 100 (5): 489–499. doi:10.1002/cpt.442. ISSN 0009-9236. PMC 5305120. PMID 27506881
- POSSIBLE FIGURE
- new inhibitor
- GREAT SOURCE
- Koepsell, H. (2021). General Overview of Organic Cation Transporters in Brain. In: Daws, L.C. (eds) Organic Cation Transporters in the Central Nervous System. Handbook of Experimental Pharmacology, vol 266. Springer, Cham. https://doi-org.byu.idm.oclc.org/10.1007/164_2021_449
- some good stuff, new inhibitors, astrocytes and BBB
- Bowman MA and Daws LC (2019) Targeting Serotonin Transporters in the Treatment of Juvenile and Adolescent Depression. Front. Neurosci. 13:156. doi: 10.3389/fnins.2019.00156
- Depression in juveniles/adolescents, okay
- Baye AM, Fanta TG, Siddiqui MK and Dawed AY (2021) The Genetics of Adverse Drug Outcomes in Type 2 Diabetes: A Systematic Review. Front. Genet. 12:675053. doi: 10.3389/fgene.2021.675053
- PMAT and metformin GI disturbances
- Antonio J. López Quiñones, Letícia Salvador Vieira and Joanne Wang Drug Metabolism and Disposition September 2022, 50 (9) 1218-1227; DOI: https://doi.org/10.1124/dmd.121.000707
- some stuff about tumors
- PMCID: PMC3902978 NIHMSID: NIHMS537012 PMID: 24054145 Catecholamine/Serotonin Interactions: Systems Thinking for Brain Function and Disease
- cool figure (9.7), need to check copyright
- Zhou M, Engel K, Wang J. Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem Pharmacol. 2007 Jan 1;73(1):147-54. doi: 10.1016/j.bcp.2006.09.008. Epub 2006 Sep 14. PMID: 17046718; PMCID: PMC1828907.
- From talk page
- Reference for structure
- http://dmd.aspetjournals.org/lookup/doi/10.1124/dmd.110.032987
- pH dependent transport
- •Bowman, Melodi A.; Gomez, Jorge A.; Mitchell, Nathan C.; Wells, Anne M.; Vitela, Melissa; Clarke, Kyra M.; Horton, Rebecca E.; Koek, Wouter; Daws, Lynette C. (2022-08-08). "Faster Serotonin Clearance in CA3 Region of Hippocampus and Antidepressant-like Effect of Decynium-22 in Juvenile Mice Are Putatively Linked to Increased Plasma Membrane Monoamine Transporter Function: Implications for Efficacy of Antidepressants in Juveniles". Cells. 11 (15): 2454. doi:10.3390/cells11152454. ISSN 2073-4409. PMC 9368098. PMID 35954298.
References
edit- ^ Muma, Nancy A.; Mi, Zhen (2015-07-15). "Serotonylation and Transamidation of Other Monoamines". ACS Chemical Neuroscience. 6 (7): 961–969. doi:10.1021/cn500329r. ISSN 1948-7193.
- ^ Nishijima, Haruo; Tomiyama, Masahiko (2016-12-15). "What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?". Frontiers in Neuroscience. 10. doi:10.3389/fnins.2016.00575. ISSN 1662-453X. PMC 5156842. PMID 28018168.
{{cite journal}}
: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link) - ^ Furihata, Tomomi; Anzai, Naohiko (2017). "Functional Expression of Organic Ion Transporters in Astrocytes and Their Potential as a Drug Target in the Treatment of Central Nervous System Diseases". Biological & Pharmaceutical Bulletin. 40 (8): 1153–1160. doi:10.1248/bpb.b17-00076. ISSN 0918-6158.
- ^ Daws, Lynette C. (2009-01-01). "Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy". Pharmacology & Therapeutics. 121 (1): 89–99. doi:10.1016/j.pharmthera.2008.10.004. ISSN 0163-7258.
- ^ Wagner, David J.; Hu, Tao; Wang, Joanne (2016-09). "Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics". Pharmacological Research. 111: 237–246. doi:10.1016/j.phrs.2016.06.002.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Weber, Brady L.; Beaver, Jasmin N.; Gilman, T. Lee (2022-11-20). "Summarizing studies using constitutive genetic deficiency to investigate behavioural influences of uptake 2 monoamine transporters". Basic & Clinical Pharmacology & Toxicology. 133 (5): 439–458. doi:10.1111/bcpt.13810. ISSN 1742-7835.
Outline of proposed changes
editClick on the edit button to draft your outline.
Examples:
|
References
editOutline of proposed changes
editClick on the edit button to draft your outline.
Now that you have compiled a bibliography, it's time to plan out how you'll improve your assigned article.
In this section, write up a concise outline of how the sources you've identified will add relevant information to your chosen article. Be sure to discuss what content gap your additions tackle and how these additions will improve the article's quality. Consider other changes you'll make to the article, including possible deletions of irrelevant, outdated, or incorrect information, restructuring of the article to improve its readability or any other change you plan on making. This is your chance to really think about how your proposed additions will improve your chosen article and to vet your sources even further. Note: This is not a draft. This is an outline/plan where you can think about how the sources you've identified will fill in a content gap. |